ENTRY       D12011                      Drug
NAME        Zanidatamab (USAN/INN)
FORMULA     C5553H8526N1482O1726S36
EXACT_MASS  124739.4891
MOL_WEIGHT  124816.3473
SEQUENCE    (Heavy chain)
            GEVQLVESGG GLVQPGGSLR LSCAASGFTF ADYTMDWVRQ APGKGLEWVG DVNPNSGGSI
            YNQRFKGRFT FSVDRSKNTL YLQMNSLRAE DTAVYYCARN LGPSFYFDYW GQGTLVTVSS
            ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYVYPPSRDE
            LTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFALV SKLTVDKSRW
            QQGNVFSCSV MHEALHNHYT QKSLSLSPG
            (Light chain)
            GDIQMTQSPS SLSASVGDRV TITCKASQDV SIGVAWYQQK PGKAPKLLIY SASYRYTGVP
            SRFSGSGSGT DFTLTISSLQ PEDFATYYCQ QYYIYPATFG QGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (heavy chain)
            GDIQMTQSPS SLSASVGDRV TITCRASQDV NTAVAWYQQK PGKAPKLLIY SASFLYSGVP
            SRFSGSRSGT DFTLTISSLQ PEDFATYYCQ QHYTTPPTFG QGTKVEIKGG SGGGSGGGSG
            GGSGGGSGEV QLVESGGGLV QPGGSLRLSC AASGFNIKDT YIHWVRQAPG KGLEWVARIY
            PTNGYTRYAD SVKGRFTISA DTSKNTAYLQ MNSLRAEDTA VYYCSRWGGD GFYAMDYWGQ
            GTLVTVSSAA EPKSSDKTHT CPPCPAPELL GGPSVFLFPP KPKDTLMISR TPEVTCVVVD
            VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN
            KALPAPIEKT ISKAKGQPRE PQVYVLPPSR DELTKNQVSL LCLVKGFYPS DIAVEWESNG
            QPENNYLTWP PVLDSDGSFF LYSKLTVDKS RWQQGNVFSC SVMHEALHNH YTQKSLSLSP
            G
            (Disulfide bride: H23-H97, H147-H203, H223-L215, H229-h261, H232-h264, H264-H324, H370-H428, h24-h89, h150-h224, h296-h356, h402-h460, L24-L89, L135-L195)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
TARGET      ERBB2 (HER2, CD340) [HSA:2064] [KO:K05083]
  PATHWAY   hsa04012(2064)  ErbB signaling pathway
            hsa05200(2064)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                ERBB2 (HER2, CD340)
                 D12011  Zanidatamab (USAN/INN)
DBLINKS     CAS: 2169946-15-8
///
